ArticleMedicina (Kaunas, Lithuania)2021

Different Effects of Empagliflozin on Markers of Mineral-Bone Metabolism in Diabetic and Non-Diabetic Patients with Stage 3 Chronic Kidney Disease.

Anna Masajtis-Zagajewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.